{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T02:31:08Z","timestamp":1789525868000,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T00:00:00Z","timestamp":1714348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T00:00:00Z","timestamp":1714348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006356","name":"University of Southern Denmark","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006356","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Child Adolesc Psychiatry"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>The aim of this study was to examine variations in use of antidepressants among children and adolescents in the three Scandinavian countries (Sweden, Norway, and Denmark). We identified new users of antidepressants (5\u201317\u00a0years) during 2007\u20132018 and described the annual incidence rate, treatment duration, concomitant psychotropic drug use, and the clinical setting of the prescribing physician (in Sweden and Denmark). Incident use of antidepressants increased by a factor 1.9 in Sweden, 1.3 in Norway and decreased by a factor 0.6 in Denmark during the study period. In Sweden, 58% of antidepressant users were covered by a prescription 12\u00a0months after initiation compared to 40% in Norway and 49% in Denmark. Also, 34% of Swedish antidepressant users were in continuous treatment after 12\u00a0months compared to 26% in Norway and 31% in Denmark. Concomitant use of other psychotropics was more common in Sweden (57%) than in Norway (37%) and Denmark (27%). During 2007\u20132018, clinicians from psychiatry settings initiated 75% of antidepressant treatments in Sweden, while this was the case for 50% of prescriptions in Denmark, although the proportion increased over time. The number of new antidepressant users is high and still rising in Sweden compared to Norway and Denmark. Swedish antidepressant users are more likely to use other psychotropics and to be covered by an antidepressant prescription after one year. Most antidepressants in Sweden are prescribed by physicians within psychiatric settings suggesting that they are based on specialized psychiatric evaluation.<\/jats:p>","DOI":"10.1007\/s00787-024-02433-7","type":"journal-article","created":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T07:02:22Z","timestamp":1714374142000},"page":"159-167","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Treatment patterns of antidepressants in children and adolescents in Scandinavia"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5962-6647","authenticated-orcid":false,"given":"Lotte","family":"Rasmussen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Bj\u00f8dstrup","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1372-4262","authenticated-orcid":false,"given":"Johan","family":"Reutfors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2245-0179","authenticated-orcid":false,"given":"Kari","family":"Furu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7525-9701","authenticated-orcid":false,"given":"Svetlana","family":"Skurtveit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randi","family":"Selmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0591-7187","authenticated-orcid":false,"given":"Per","family":"Damkier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7637-3730","authenticated-orcid":false,"given":"Mette","family":"Bliddal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9700-2739","authenticated-orcid":false,"given":"Rikke","family":"Wesselhoeft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,29]]},"reference":[{"key":"2433_CR1","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40360-023-00664-z","volume":"24","author":"D Dubrall","year":"2023","unstructured":"Dubrall D, Fekete S, Leitzen S et al (2023) Selective serotonin reuptake inhibitors and suicidality in children and young adults: analyses of pharmacovigilance databases. BMC Pharmacol Toxicol 24:22. https:\/\/doi.org\/10.1186\/s40360-023-00664-z","journal-title":"BMC Pharmacol Toxicol"},{"key":"2433_CR2","unstructured":"European Medicines Agency (2005) European Medicines Agency finalises review of antidepressants in children and adolescents"},{"key":"2433_CR3","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1001\/archpsyc.63.3.332","volume":"63","author":"TA Hammad","year":"2006","unstructured":"Hammad TA, Laughren T, Racoosin J (2006) Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry 63:332\u2013339. https:\/\/doi.org\/10.1001\/archpsyc.63.3.332","journal-title":"Arch Gen Psychiatry"},{"key":"2433_CR4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i65","volume":"352","author":"T Sharma","year":"2016","unstructured":"Sharma T, Guski LS, Freund N, G\u00f8tzsche PC (2016) Suicidality and aggression during antidepressant treatment: systematic review and meta-analyses based on clinical study reports. BMJ 352:i65. https:\/\/doi.org\/10.1136\/bmj.i65","journal-title":"BMJ"},{"key":"2433_CR5","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1056\/NEJMp038248","volume":"350","author":"B Vitiello","year":"2004","unstructured":"Vitiello B, Swedo S (2004) Antidepressant medications in children. N Engl J Med 350:1489\u20131491. https:\/\/doi.org\/10.1056\/NEJMp038248","journal-title":"N Engl J Med"},{"key":"2433_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-019-02711-3","author":"D Piovani","year":"2019","unstructured":"Piovani D, Clavenna A, Bonati M (2019) Prescription prevalence of psychotropic drugs in children and adolescents: an analysis of international data. Eur J Clin Pharmacol. https:\/\/doi.org\/10.1007\/s00228-019-02711-3","journal-title":"Eur J Clin Pharmacol"},{"key":"2433_CR7","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.euroneuro.2016.02.001","volume":"26","author":"CJ Bachmann","year":"2016","unstructured":"Bachmann CJ, Aagaard L, Burcu M et al (2016) Trends and patterns of antidepressant use in children and adolescents from five western countries, 2005\u20132012. Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol 26:411\u2013419. https:\/\/doi.org\/10.1016\/j.euroneuro.2016.02.001","journal-title":"Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol"},{"key":"2433_CR8","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1111\/acps.12633","volume":"134","author":"I Hartz","year":"2016","unstructured":"Hartz I, Skurtveit S, Hjellvik V et al (2016) Antidepressant drug use among adolescents during 2004\u20132013: a population-based register linkage study. Acta Psychiatr Scand 134:420\u2013429. https:\/\/doi.org\/10.1111\/acps.12633","journal-title":"Acta Psychiatr Scand"},{"key":"2433_CR9","doi-asserted-by":"publisher","DOI":"10.1111\/acps.13116","author":"R Wesselhoeft","year":"2019","unstructured":"Wesselhoeft R, Jensen PB, Talati A et al (2019) Trends in antidepressant use among children and adolescents: a Scandinavian drug utilization study. Acta Psychiatr Scand. https:\/\/doi.org\/10.1111\/acps.13116","journal-title":"Acta Psychiatr Scand"},{"key":"2433_CR10","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1023\/A:1009460010196","volume":"7","author":"S Holm","year":"1999","unstructured":"Holm S, Liss PE, Norheim OF (1999) Access to health care in the Scandinavian countries: ethical aspects. Health Care Anal HCA J Health Philos Policy 7:321\u2013330. https:\/\/doi.org\/10.1023\/A:1009460010196","journal-title":"Health Care Anal HCA J Health Philos Policy"},{"key":"2433_CR11","unstructured":"European Medicines Agency. https:\/\/www.ema.europa.eu\/en"},{"key":"2433_CR12","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/pds.1294","volume":"16","author":"B Wettermark","year":"2007","unstructured":"Wettermark B, Hammar N, Fored CM et al (2007) The new Swedish Prescribed Drug Register\u2013opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf 16:726\u2013735. https:\/\/doi.org\/10.1002\/pds.1294","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2433_CR13","doi-asserted-by":"publisher","DOI":"10.5324\/nje.v18i2.23","author":"K Furu","year":"2008","unstructured":"Furu K (2008) Establishment of the nationwide Norwegian Prescription Database (NorPD)\u2014new opportunities for research in pharmacoepidemiology in Norway. Nor Epidemiol. https:\/\/doi.org\/10.5324\/nje.v18i2.23","journal-title":"Nor Epidemiol"},{"key":"2433_CR14","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1093\/ije\/dyw213","volume":"46","author":"A Potteg\u00e5rd","year":"2017","unstructured":"Potteg\u00e5rd A, Schmidt SAJ, Wallach-Kildemoes H et al (2017) Data resource profile: the Danish National Prescription Registry. Int J Epidemiol 46:798\u2013798f. https:\/\/doi.org\/10.1093\/ije\/dyw213","journal-title":"Int J Epidemiol"},{"key":"2433_CR15","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.1742-7843.2009.00494.x","volume":"106","author":"K Furu","year":"2010","unstructured":"Furu K, Wettermark B, Andersen M et al (2010) The Nordic countries as a cohort for pharmacoepidemiological research. Basic Clin Pharmacol Toxicol 106:86\u201394. https:\/\/doi.org\/10.1111\/j.1742-7843.2009.00494.x","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"2433_CR16","unstructured":"WHOCC\u2014ATC\/DDD Index. https:\/\/www.whocc.no\/atc_ddd_index\/. Accessed 6 July 2023"},{"key":"2433_CR17","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1002\/pds.4582","volume":"27","author":"L Rasmussen","year":"2018","unstructured":"Rasmussen L, Pratt N, Hansen MR et al (2018) Using the \u201cproportion of patients covered\u201d and the Kaplan-Meier survival analysis to describe treatment persistence. Pharmacoepidemiol Drug Saf 27:867\u2013871. https:\/\/doi.org\/10.1002\/pds.4582","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2433_CR18","unstructured":"Swedish National Board of Health and Welfare (2018) Inrapporterade depressioner och \u00e5ngestsyndrom bland barn och unga vuxna \u2013 utvecklingen till och med 2018"},{"key":"2433_CR19","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.sapharm.2017.07.011","volume":"14","author":"M Green Lauridsen","year":"2018","unstructured":"Green Lauridsen M, K\u00e4lvemark Sporrong S (2018) How does media coverage effect the consumption of antidepressants? A study of the media coverage of antidepressants in Danish online newspapers 2010\u20132011. Res Soc Adm Pharm 14:638\u2013644. https:\/\/doi.org\/10.1016\/j.sapharm.2017.07.011","journal-title":"Res Soc Adm Pharm"},{"key":"2433_CR20","unstructured":"Institute for Health Metrics and Evaluation (IHME). GBD compare data visualization. Seattle, WA: IHME, University of Washington, 2020. http:\/\/vizhub.healthdata.org\/gbd-compare. Accessed 12 Jan 2024"},{"key":"2433_CR21","unstructured":"The Ministry of the Interior and Health (2019) Vejledning om medikamentel behandling af b\u00f8rn og unge med psykiske lidelser [Guideline on the use of medicine in children and adolescents with psychiatric disorders]"},{"key":"2433_CR22","unstructured":"The Ministry of the Interior and Health (2007) Vejledning om medikamentel behandling af b\u00f8rn og unge med psykiske lidelser [Guideline on the use of medicine in children and adolescents with psychiatric disorders]. https:\/\/www.retsinformation.dk\/eli\/retsinfo\/2007\/10332. Accessed 24 Feb 2015"},{"key":"2433_CR23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00787-019-01416-3","volume":"29","author":"E Barrett","year":"2020","unstructured":"Barrett E, Jacobs B, Klasen H et al (2020) The child and adolescent psychiatry: study of training in Europe (CAP-STATE). Eur Child Adolesc Psychiatry 29:11\u201327. https:\/\/doi.org\/10.1007\/s00787-019-01416-3","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"2433_CR24","unstructured":"Swedish National Board of Health and Welfare (2021) Nationella riktlinjer f\u00f6r v\u00e5rd vid depression och \u00e5ngestsyndrom, 2021. [National guidelines for care in cases of depression and anxiety disorders]"},{"key":"2433_CR25","unstructured":"Norsk barne- og ungdomspsykiatrisk forening Faglig veileder for barne- og ungdomspsykiatri [Guidance in child- and adolescent psychiatry], 4. utgave"},{"key":"2433_CR26","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1007\/s00228-012-1233-6","volume":"68","author":"LK Saastamoinen","year":"2012","unstructured":"Saastamoinen LK, Wallin M, Lavikainen P et al (2012) Treatment duration with selective serotonin reuptake inhibitors among children and adolescents in Finland: a nationwide register study. Eur J Clin Pharmacol 68:1109\u20131117. https:\/\/doi.org\/10.1007\/s00228-012-1233-6","journal-title":"Eur J Clin Pharmacol"},{"key":"2433_CR27","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s00787-014-0523-1","volume":"23","author":"A Potteg\u00e5rd","year":"2014","unstructured":"Potteg\u00e5rd A, Zo\u00ebga H, Hallas J, Damkier P (2014) Use of SSRIs among Danish children: a nationwide study. Eur Child Adolesc Psychiatry 23:1211\u20131218. https:\/\/doi.org\/10.1007\/s00787-014-0523-1","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"2433_CR28","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.12610","author":"L Rasmussen","year":"2016","unstructured":"Rasmussen L, Valentin J, Gesser KM et al (2016) Validity of the prescriber information in the Danish National Prescription Registry. Basic Clin Pharmacol Toxicol. https:\/\/doi.org\/10.1111\/bcpt.12610","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"2433_CR29","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1001\/jamapsychiatry.2022.4165","volume":"80","author":"M Bliddal","year":"2023","unstructured":"Bliddal M, Rasmussen L, Andersen JH et al (2023) Psychotropic medication use and psychiatric disorders during the COVID-19 pandemic among Danish children, adolescents, and young adults. JAMA Psychiat 80:176\u2013180. https:\/\/doi.org\/10.1001\/jamapsychiatry.2022.4165","journal-title":"JAMA Psychiat"},{"key":"2433_CR30","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.jad.2022.11.068","volume":"323","author":"M Tiger","year":"2023","unstructured":"Tiger M, Wesselhoeft R, Karlsson P et al (2023) Utilization of antidepressants, anxiolytics, and hypnotics during the COVID-19 pandemic in Scandinavia. J Affect Disord 323:292\u2013298. https:\/\/doi.org\/10.1016\/j.jad.2022.11.068","journal-title":"J Affect Disord"}],"container-title":["European Child &amp; Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00787-024-02433-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00787-024-02433-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00787-024-02433-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T04:32:20Z","timestamp":1738902740000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00787-024-02433-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,29]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["2433"],"URL":"https:\/\/doi.org\/10.1007\/s00787-024-02433-7","relation":{},"ISSN":["1018-8827","1435-165X"],"issn-type":[{"value":"1018-8827","type":"print"},{"value":"1435-165X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,29]]},"assertion":[{"value":"17 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"LR, MB, KF, SVSK, RS, PD and RW declare no conflict of interest. JR is employed at the Centre for Pharmacoepidemiology, Karolinska Institutet, which receives grants from several entities (pharmaceutical companies, regulatory authorities, and contract research organizations) for performance of drug safety and drug utilization studies, with no relation to the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Danish Data Protection Agency (10.080). According to Danish legislation, approval from an ethics Committee is not required for registry-based studies. The Regional Committee for Medical Research Ethics (2010\/131) and the Norwegian Data Protection Authority (10\/00447-5) approved the register linkage. The use of Swedish data for this study was approved by the Swedish Ethical Review Authority (no. 2017\/1236\u201331\/2).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}